Blueprint Medicines Alternatives & Competitors
12 companies similar to Blueprint Medicines — Striving to improve and extend patients' lives
Companies similar to Blueprint Medicines
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
Immunocore
Science to Transform Lives
Abingdon, United Kingdom
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
Rival Readout
Competing with Blueprint Medicines? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Actio Biosciences, Inc.
From One To Many.
San Diego, United States
Celsius Therapeutics
On a quest to leverage the power of single cell genomics to discover novel drug targets an...
Cambridge, United States
Iovance Biotherapeutics, Inc.
Iovance is a patient-centric, collaborative organization that is driven to change the way...
San Carlos, United States
NBE-Therapeutics AG
Next generation antibody drug conjugates
Basel, Switzerland
Denmark
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
Gritstone bio
A lean biotech company aiming to develop revolutionary immune-based treatment for various...
Emeryville, United States
Minerva Biotechnologies
We see the future first
Waltham, United States
About Blueprint Medicines
Blueprint Medicines is a noteworthy player in the global biopharmaceutical landscape, underpinned by its slogan, "Striving to improve and extend patients' lives." Founded in 2011 and headquartered in the United States, Blueprint Medicines has anchored itself in the biotechnology and health care sectors, expanding its i...
Therapeutic Development, Drug Delivery, Clinical Trial Management, Scientific Research, Patient Support Programs
Patients with Systemic Mastocytosis, Patients with Gastrointestinal Stromal Tumor, Healthcare Professionals, Pharmaceutical Distributors, Medical Researchers
Biopharmaceuticals, Drug Discovery, Oncology, Hematology, Allergy, Inflammation, Targeted Therapy, Cancer Genomics, Personalized Medicine, Mast Cell Diseases, Systemic Mastocytosis, Solid Tumors, Clinical Trials, Cancer Data Revolution, Rational Drug Development
B2B, B2C, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Blueprint Medicines: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Blueprint Medicines on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
